Resource Library
Discover Kymera’s research and resources on our exciting platform, pipeline, and additional cutting-edge technologies.
Related Resources
October 27, 2021
Understanding PK/PD for Development of STAT3 Degraders in Oncology Indications
4th Annual TPD Summit
Liquid Tumors
Solid Tumors
Read More
July 12, 2021
Targeting STAT3 with Selective Protein Degraders for the Treatment of PTCL
13th Annual T-Cell Lymphoma Forum
PTCL
Read More
February 16, 2021
Discovery of Potent and Selective STAT3 Targeted Protein Degraders with Excellent in vitro and in vivo ADME Properties
Oxford Global’s Virtual Symposium: Targeted Protein Degradation & PROTAC
Liquid Tumors
Solid Tumors
Read More
December 7, 2020
Mechanisms of Anti-Tumor Activity of STAT3 Degraders in Lymphoma
62nd American Society of Hematology (ASH) Virtual Annual Meeting and Exposition
Liquid Tumors
Read More
June 22, 2020
A STAT3-selective targeted protein degrader decreases the immune-suppressive tumor microenvironment and drives anti-tumor activity in preclinical models
American Association for Cancer Research (AACR) Virtual Annual Meeting II
Liquid Tumors
Solid Tumors
Read More
December 7, 2019
Small molecule-induced, selective STAT3 degradation leads to anti-tumor activity in STAT3-dependent heme malignancies
American Society of Hematology (ASH) Annual Meeting
Liquid Tumors
Read More
October 26, 2019
Discovery of KYM-003, a potent and selective STAT3 degrader with anti-tumor activity in heme malignancies
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Liquid Tumors
Read More